Xingnong Ye

Low Humoral Immune Response and Ineffective Clearance of SARS-Cov-2 in a COVID-19 Patient With CLL During a 69-Day Follow-Up

Xingnong Ye, Xiaofang Xiao, Bin Li et al. · Frontiers in Oncology · 2020 · 35 citations · Full text

Veterinary Medicine, Hematology, Immunology +11

Epigenetic priming with decitabine followed by low-dose idarubicin/cytarabine has an increased anti-leukemic effect compared to traditional chemotherapy in high-risk myeloid neoplasms

Xingnong Ye, Xinping Zhou, Juying Wei et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2015 · 31 citations

Medicine, Pharmacology, Pharmacotherapy +16

Characteristics and prognosis analysis of additional chromosome abnormalities in newly diagnosed acute promyelocytic leukemia treated with arsenic trioxide as the front-line therapy

Yinjun Lou, Shanshan Suo, Hongyan Tong et al. · Leukemia Research · 2013 · 25 citations

Life Sciences, Hematology, Oncology +17

All-trans retinoic acid enhances the cytotoxic effect of decitabine on myelodysplastic syndromes and acute myeloid leukaemia by activating the RARα-Nrf2 complex

Lu Wang, Qi Zhang, Li Ye et al. · British Journal of Cancer · 2022 · 18 citations · Full text

Medicine, Oncology, Pharmacology +16

The incidence, risk factors, and survival of acute myeloid leukemia secondary to myelodysplastic syndrome: A population‐based study

Xingnong Ye, Dan Chen, Yan Zheng et al. · Hematological Oncology · 2019 · 13 citations · Full text

Medicine, Oncology, Clinical Epidemiology +12